Dawn C. Willoughby Sells 54,205 Shares of Clorox Co (CLX) Stock

Clorox Co (NYSE:CLX) COO Dawn C. Willoughby sold 54,205 shares of the firm’s stock in a transaction dated Tuesday, November 6th. The shares were sold at an average price of $157.39, for a total value of $8,531,324.95. Following the completion of the sale, the chief operating officer now directly owns 37,044 shares in the company, valued at approximately $5,830,355.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Dawn C. Willoughby also recently made the following trade(s):

  • On Wednesday, September 5th, Dawn C. Willoughby sold 3,387 shares of Clorox stock. The shares were sold at an average price of $148.01, for a total value of $501,309.87.

CLX opened at $158.77 on Friday. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.65 and a current ratio of 1.07. Clorox Co has a 1 year low of $113.57 and a 1 year high of $159.17. The company has a market cap of $20.18 billion, a P/E ratio of 25.36, a P/E/G ratio of 3.88 and a beta of 0.28.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 31st. The company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.59 by $0.03. Clorox had a return on equity of 102.65% and a net margin of 13.59%. The business had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period last year, the company earned $1.46 EPS. Clorox’s revenue for the quarter was up 4.2% compared to the same quarter last year. Research analysts forecast that Clorox Co will post 6.31 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Investors of record on Wednesday, October 31st will be given a dividend of $0.96 per share. The ex-dividend date is Tuesday, October 30th. This represents a $3.84 annualized dividend and a yield of 2.42%. Clorox’s payout ratio is 61.34%.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Berkshire Asset Management LLC PA grew its position in Clorox by 17.6% during the 3rd quarter. Berkshire Asset Management LLC PA now owns 3,119 shares of the company’s stock worth $469,000 after acquiring an additional 467 shares during the last quarter. Carillon Tower Advisers Inc. grew its position in Clorox by 82.8% during the 2nd quarter. Carillon Tower Advisers Inc. now owns 109,150 shares of the company’s stock worth $14,763,000 after acquiring an additional 49,450 shares during the last quarter. Victory Capital Management Inc. grew its position in Clorox by 0.4% during the 2nd quarter. Victory Capital Management Inc. now owns 105,329 shares of the company’s stock worth $14,246,000 after acquiring an additional 456 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its position in Clorox by 7.2% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 63,730 shares of the company’s stock worth $8,620,000 after acquiring an additional 4,281 shares during the last quarter. Finally, Homrich & Berg grew its position in Clorox by 6.5% during the 2nd quarter. Homrich & Berg now owns 9,021 shares of the company’s stock worth $1,220,000 after acquiring an additional 552 shares during the last quarter. Institutional investors and hedge funds own 78.35% of the company’s stock.

A number of brokerages recently weighed in on CLX. Bank of America raised their price objective on Clorox from $130.00 to $140.00 and gave the company a “neutral” rating in a report on Monday, July 16th. Goldman Sachs Group cut Clorox from a “neutral” rating to a “sell” rating and decreased their price objective for the company from $127.00 to $112.00 in a report on Tuesday, July 17th. They noted that the move was a valuation call. UBS Group began coverage on Clorox in a report on Wednesday, July 18th. They set a “sell” rating and a $110.00 price objective on the stock. BMO Capital Markets reissued a “buy” rating and set a $153.00 price objective on shares of Clorox in a report on Friday, August 3rd. Finally, Atlantic Securities began coverage on Clorox in a report on Thursday, September 20th. They set a “neutral” rating and a $151.00 price objective on the stock. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $141.64.

ILLEGAL ACTIVITY NOTICE: This article was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The correct version of this article can be read at https://sportsperspectives.com/2018/11/10/dawn-c-willoughby-sells-54205-shares-of-clorox-co-clx-stock.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: Discount Rate

Insider Buying and Selling by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply